Deferasirox for managing transfusional iron overload in people with sickle cell disease

BACKGROUND: Sickle cell disease (SCD) is a group of genetic haemoglobin disorders, that occurs in about 2.2 per 1000 births worldwide. Increasingly, some people with SCD develop secondary iron overload due to occasional red blood cell transfusions or are on long‐term transfusion programmes for e.g....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane Database Syst Rev
Hauptverfasser: Meerpohl, Joerg J, Schell, Lisa K, Rücker, Gerta, Motschall, Edith, Fleeman, Nigel, Niemeyer, Charlotte M, Bassler, Dirk
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Ltd 2014
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489379/
https://ncbi.nlm.nih.gov/pubmed/24893174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007477.pub3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge